Cite

HARVARD Citation

    Mulet, N. et al. (2018). Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer. Expert opinion on pharmacotherapy. pp. 623-629. [Online]. 
  
Back to record